Dialysis-Associated Hypotension: Mechanisms, Recognition, and Prevention

Intradialytic hypotension (IDH)—a systolic BP drop >20 mmHg or MAP decrease >10 mmHg with symptoms—affects 15–30% of hemodialysis sessions, making it the most common acute complication.

Pathophysiology

  • Ultrafiltration rate > plasma refill rate: Intravascular volume depletion without adequate interstitial fluid mobilization.
  • Autonomic neuropathy: Impaired vasoconstriction and venoconstriction (common in diabetes, elderly).
  • Dialysate factors: High temperature (>37°C), low sodium, acetate buffer (historical).
  • Medication timing: Antihypertensives taken pre-dialysis blunt compensatory responses.
  • Cardiac dysfunction: Reduced systolic/diastolic reserve limits compensatory output increase.

Clinical Presentation

  • Dizziness, nausea, yawning, restlessness
  • Muscle cramps (calf, abdominal)
  • Severe: syncope, seizures, angina, ischemic stroke

Prevention & Management Bundle

  1. Individualize UF rate & target weight: ≤10–13 mL/kg/hr; assess dry weight clinically + bioimpedance.
  2. Cool dialysate (35–35.5°C): Promotes vasoconstriction, reduces IDH by 30–50%.
  3. Sodium modeling/profiling: Higher early dialysate Na+ → plasma refill.
  4. Midodrine 5–10 mg pre-HD (alpha-agonist) or other vasoconstrictors if recurrent.
  5. Hold antihypertensives on dialysis days (individualize).
  6. Frequent BP monitoring: Every 15–30 min; automated alerts.
  7. Supine/trendelenburg positioning at symptom onset.

Proactive, protocolized IDH prevention preserves vascular access, cardiac function, and quality of life.

Kidney Disease - Related Articles